Log in

LON:PEBI - Port Erin Biopharma Investments Share Price, Forecast & News

Today's Range N/A
50-Day Range
MA: GBX 4.50
52-Week Range N/A
Average Volume7,434 shs
Market Capitalization£1.04 million
P/E RatioN/A
Dividend YieldN/A
Port Erin Biopharma Investments Limited is a principal investment firm specializing in investments in equity and equity related products. The firm invests in quoted and unquoted companies. It prefers to invest in the biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. Port Erin Biopharma Investments Limited was founded on May 3, 2011 and is based in Isle of Man, United Kingdom.

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual Sales£28,300.00
Book ValueGBX 8.10 per share



Market Cap£1.04 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PEBI News and Ratings via Email

Sign-up to receive the latest news and ratings for PEBI and its competitors with MarketBeat's FREE daily newsletter.

Port Erin Biopharma Investments (LON:PEBI) Frequently Asked Questions

What is Port Erin Biopharma Investments' stock symbol?

Port Erin Biopharma Investments trades on the London Stock Exchange (LON) under the ticker symbol "PEBI."

Has Port Erin Biopharma Investments been receiving favorable news coverage?

Media coverage about PEBI stock has been trending negative on Sunday, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Port Erin Biopharma Investments earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Port Erin Biopharma Investments.

Who are some of Port Erin Biopharma Investments' key competitors?

Who are Port Erin Biopharma Investments' key executives?

Port Erin Biopharma Investments' management team includes the folowing people:
  • Mr. Denham Hervey Newall Eke, CFO, Fin. Director & Director (Age 67)

How do I buy shares of Port Erin Biopharma Investments?

Shares of PEBI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How big of a company is Port Erin Biopharma Investments?

Port Erin Biopharma Investments has a market capitalization of £0.00 and generates £28,300.00 in revenue each year. View Additional Information About Port Erin Biopharma Investments.

What is Port Erin Biopharma Investments' official website?

The official website for Port Erin Biopharma Investments is http://www.porterinbiopharma.com/.

How can I contact Port Erin Biopharma Investments?

Port Erin Biopharma Investments' mailing address is 18 Athol Street, DOUGLAS, IM1 1JA, Isle of Man. The company can be reached via phone at +44-1624-620711.

MarketBeat Community Rating for Port Erin Biopharma Investments (LON PEBI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  55 (Vote Underperform)
Total Votes:  113
MarketBeat's community ratings are surveys of what our community members think about Port Erin Biopharma Investments and other stocks. Vote "Outperform" if you believe PEBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PEBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel